TOPX Summit 2024

18-19 January 2024


Ricarda Finnern | Chief Scientific Officer, LenioBio GmbH

Chief Scientific Officer responsible for the overall scientific company strategy. Global program head and molecular immunologist with over 25 years’ experience in academic, contract research organizations (Fraunhofer-Gesellschaft) and pharmaceutical industry (Dyax s.a., Bayer AG). ‘Mini-MBA’ from Falconbury Ltd., London. Co-Founder and CSO of AAvantgarde AG. Extensive line management experience (cross-functional and cross-cultural team member) and budget responsibilities. Ten years work experience abroad in England, USA, Belgium and Switzerland.

Extensive experience in global program management and alliance management. Expert in the development of pharmaceutical products, e.g. small molecules, antibodies, bispecific antibodies, and antibody-drug-conjugates in autoimmune indications, oncology and immuno-oncology.

Agile leader with strategic mind-set, problem solving, communication and people-management skills. Track record of delivering results within timelines and budget. I am known to build high-performance teams and attract, retain and develop talent. Creating an environment where each team member can perform, innovate and develop is very important to me.

VivArt-X

About LenioBio GmbH

LenioBio is on a mission to redefine biopharma manufacturing. LenioBio GmbH is a platform company based in Germany that develops and commercializes ‘ALiCE’, a eukaryotic cell-free lysate capable to produce all kinds of proteins within days by just adding a DNA template encoding the protein of interest – fast, flexible, scalable, easy to use.

Powered by:
Hyphen Projects BV   

    Connect with us                  

Join TOPX

Privacy Policy
Terms & Conditions 
Chamber of Commerce:
32110979
VAT no: NL8184.34.491.B01

         
  
  
  
                                    

© Copyright 2020 by Hyphen Projects